New radiation technique aims to stop blood Cancer's return after transplant
NCT ID NCT04187105
Summary
This study is testing if adding a precise, targeted form of radiation to the standard treatment before a stem cell transplant can kill more cancer cells in the bone marrow and lower the chance of the disease coming back. It is for adults aged 18-75 with acute leukemia or myelodysplastic syndrome (MDS) who need a transplant from a partially matched donor. The main goal is to see how many patients are alive, free of their cancer, and without major transplant complications one year after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Illinois Cancer Center
RECRUITINGChicago, Illinois, 60612, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.